Bristol-Myers Squibb (BMY) Tops Q1 EPS by 28c ; Offers Guidance
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $66.82 -1.87%
Revenue Growth %: +3.2%
Financial Fact:
Net Sales: 4.92B
Today's EPS Names:
PMCB, CULP, HURC, More
Revenue Growth %: +3.2%
Financial Fact:
Net Sales: 4.92B
Today's EPS Names:
PMCB, CULP, HURC, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $1.80, $0.28 better than the analyst estimate of $1.52. Revenue for the quarter came in at $11.2 billion versus the consensus estimate of $10.68 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2025 EPS of $6.70-$7.00, versus the consensus of $6.74. Bristol-Myers Squibb sees FY2025 revenue of $45.8-46.8 billion, versus the consensus of $45.76 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Colgate-Palmolive, Nike dropped from S&P 100
- Molson Coors Brewing (TAP) dropped from S&P 500
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
